Cancer clinical trials in the region Occitanie
132 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT04954820
Neuroendocrine tumor
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Jean Perrin (Clermont Ferrand ), Institut du cancer de Montpellier (Montpellier), Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest) (and 22 more...)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05384626
Locally Advanced
Metastatic
Metastatic Castration-resistant
Other mutation
BRAF
MET
HER2
RET
NTRK-1/2/3
KRAS G12C
KRAS non G12C
BRCA 1/2
AKT
PIK3CA
PALB2
ESR
FGFR
PTEN
MSI/dMMR
ATM
CDK12
HOXB13
CHEK 1/2
NRAS
Systemic Treatment-Naive
Gustave Roussy (Villejuif), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Nuvalent Inc.
Phase 2
Lung cancer
#NCT05384626
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ALK
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Gustave Roussy (Villejuif), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Nuvalent Inc.
Phase 2
Colon cancer
Rectal cancer
#NCT03475953
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Targeted therapy
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut du cancer de Montpellier (Montpellier), Institut Curie - Paris (Paris), Gustave Roussy (Villejuif) (and 2 more...)
Institut Bergonié
Phase 2
Lymphoma
#NCT03930953
B cell lymphoma
2
3 or more
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil), Centre Henri Becquerel (Rouen ), Hôpital Saint Louis AP-HP (Paris), Institut Bergonié (Bordeaux), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier) (and 3 more...)
Celgene
Phase 2
Lung cancer
#NCT05142696
SCLC (Small Cell Lung Cancer)
Locally Advanced
Metastatic
Systemic Treatment-Naive
Immunotherapy
Hôpital de la Timone AP-HM (Marseille), Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier)
Novartis
Phase 2
Lymphoma
#NCT04802590
B cell lymphoma
Mantel cell lymphoma
CD20
None
> 60 ml/min
50-60 ml/min
Systemic Treatment-Naive
None
Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Institut Paoli-Calmettes (Marseille), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Institut de Cancérologie et d’Hématologie Universitaire de Saint-Étienne (CHU Saint-Étienne) (Saint-Priest-en-Jarez) (and 30 more...)
Organisation de recherche universitaire sur le lymphome
Phase 2
Lung cancer
#NCT05617963
SCLC (Small Cell Lung Cancer)
Locally Advanced
Localized
Systemic Treatment-Naive
Systemic Treatment-Naive
CHU Caen Normandie (Caen), Centre Hospitalier du Pays d'Aix (Aix-en-Provence), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier de la Côte Basque (Bayonne), Centre François Baclesse (Caen ) (and 23 more...)
UNICANCER
Phase 2
Breast cancer
#NCT05386108
HER2 Negative
HR Positive
Metastatic
Chemotherapy
Hormone therapy
Targeted therapy
Systemic Treatment-Naive
Centre de Cancérologie du Grand Montpellier (Montpellier), Hôpital Pitié Salpêtrière - AP-HP (Paris), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), IUCT Oncopôle (Toulouse)
Stemline Therapeutics, Inc.
Phase 2
Breast cancer
#NCT05041842
HER2 Positive
Metastatic
Targeted therapy
Systemic Treatment-Naive
Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), Centre Hospitalier Universitaire de Besançon (Besançon), Institut Sainte Catherine (Avignon), Centre Jean Perrin (Clermont Ferrand ), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ) (and 22 more...)
UNICANCER